Inside the research
Teleflex Incorporated
TFX Research profile · latest available data
Price overview
$122.07
▲ +1.98 (+1.6%)
| 52w hi | $142.05 |
|---|---|
| 52w lo | $99.54 |
| Vol | 857.30K |
| As of | 25 Sep 2026 |
The Verdict
Our score -0.03
| Short | +0.10 |
|---|---|
| Medium | +0.01 |
| Long | -0.35 |
computed 2026-09-27
Key fundamentals
Teleflex Incorporated
Healthcare · Medical Instruments & Supplies
| Market cap | $5.17B |
|---|---|
| Enterprise value | $7.79B |
| Forward P/E | 11.15x |
| EV / EBITDA | 19.27x |
| P / S (ttm) | 2.29x |
| Profit margin | -45.8% |
| Return on equity | -0.7% |
| Revenue growth | +28.9% |
| Earnings growth | -17.3% |
| Debt / equity | 101.10 |
Layer Breakdown
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | +0.00 | |
| Sector | +0.08 | |
| Technical | -0.05 | |
| Earnings | +0.00 | |
| Sentiment | +0.16 |
macro × 1.00 · 2026-09-27
Business overview
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company offers vascular and emergency medicine products comprising Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, measurement of blood pressure, and collection of blood samples; intraosseous access systems consisting of EZ-IO intraosseous vascular access systems, and Arrow FAST1 sternal intraosseous infusion systems; and hemostatic products, including external hemostats and trauma products under the QuikClot brand. It also provides interventional products, including various coronary catheters, structural heart support devices, and peripheral intervention products platforms; GuideLiner, Turnpike, and TrapLiner catheters; MANTA vascular closure devices and Arrow OnControl powered bone biopsy systems; and coronary and peripheral medical devices, such as drug-coated balloons, stents, and balloon catheters. In addition, the company offers surgical products, including metal and polymer ligating clips using manual and automatic applier system, fascial closure surgical systems used in laparoscopic surgical procedures, percutaneous surgical systems, powered bariatric staplers, and other surgical instruments under the Weck, MiniLap, Pleur-Evac, Deknatel, KMedic, Pilling, and Titan SGS brands. It serves hospitals, healthcare providers, and medical device manufacturers. The company also sells its products online. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.
Risk Metrics
| Beta vs SPX | 0.77 |
|---|---|
| Corr SPX | 0.32 |
| Annual vol | 39.3% |
| Annual ret | -26.3% |
| Sharpe | -0.67 |
| Max DD | -59.4% |
Window: 504 trading days (504 obs)
Material Events
| Date | Event | 8-K |
|---|---|---|
| 2026-08-07 | Other Material Event | read |
| 2026-08-06 | Earnings Release, Reg FD Disclosure… | read |
| 2026-08-03 | Acquisition / Disposition, Reg FD Disclosure… | read |
| 2026-06-15 | Material Agreement, Material Obligation… | read |
| 2026-06-09 | Officer / Director Change | read |
| 2026-06-02 | Other Material Event, Exhibits | read |
| 2026-06-01 | Reg FD Disclosure, Other Material Event… | read |
| 2026-05-27 | Material Agreement, Material Obligation… | read |
| 2026-05-20 | Shareholder Vote | read |
| 2026-05-07 | Earnings Release, Reg FD Disclosure… | read |
| 2026-04-30 | Officer / Director Change, Exhibits | read |
| 2026-03-27 | Reg FD Disclosure, Exhibits | read |
Insider Trades
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-08 | Weidman Jason R. | President and CEO | Grant | 53.98K | — |
| 2026-06-08 | RANDLE STUART A | Grant | 995 | — | |
| 2026-06-08 | RANDLE STUART A | Grant | 4.66K | — | |
| 2026-06-07 | RANDLE STUART A | Withheld for tax | 4.05K | $526.37K | |
| 2026-05-15 | TOKICH MICHAEL J | Grant | 1.09K | — | |
| 2026-05-15 | Patil Neena M | Grant | 1.09K | — | |
| 2026-05-15 | Duncan Candace H | Grant | 1.09K | — | |
| 2026-05-15 | Ryu Jaewon | Grant | 1.09K | — | |
| 2026-05-15 | Krakauer Andrew A | Grant | 1.09K | — | |
| 2026-05-15 | HAGGERTY GRETCHEN R | Grant | 1.09K | — |
Flow & Concentration
| Insider 180d net | $0 |
|---|---|
| Insider buys / sells | 0 / 0 |
| Insider bias | Neutral |
| 13F holders | 8 |
| Top-5 share | 98.3% |
| HHI | 2,505 (concentrated) |
Top Holders
| Holder | Value | Shares |
|---|---|---|
| State Street Corp | $188.12M | 1.48M |
| Millennium Management | $182.80M | 1.44M |
| Citadel Advisors | $145.72M | 1.15M |
| Capital Research / Capital World | $49.68M | 391.89K |
| AQR Capital Management | $35.21M | 280.64K |
| Renaissance Technologies | $9.60M | 75.70K |
| Fidelity / FMR LLC | $897.32K | 7.08K |
| T. Rowe Price Group | $5.72K | 45.16K |
As of 2026-06-30
Dividends
| Yield (TTM) | 0.56% |
|---|---|
| $ / share (TTM) | $0.68 |
| 5y CAGR | +0.0% |
Annual dividend per share
| 2021 | $1.36 |
|---|---|
| 2022 | $1.36 |
| 2023 | $1.36 |
| 2024 | $1.36 |
| 2025 | $1.36 |
| 2026 | $0.34 |
SEC Filings
The Long Run
FY 2010–2025 · 16 years
| Line | Latest | CAGR | Trend |
|---|---|---|---|
| Revenue | $1.99B | +0.8% | |
| Gross profit | $1.04B | +2.0% | |
| Operating income | -$71.77M | +4.8% | |
| Net income | $356.33M | +4.5% |
Indices
Recent Sessions
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Sep 25 | $120.47 | $123.05 | $118.31 | $122.07 | 857.30K |
| Sep 24 | $122.34 | $123.14 | $119.86 | $120.09 | 869.60K |
| Sep 23 | $124.71 | $125.16 | $121.12 | $121.75 | 832.60K |
| Sep 22 | $126.35 | $127.07 | $124.16 | $124.90 | 777.10K |
| Sep 21 | $124.84 | $126.23 | $123.10 | $124.80 | 815.20K |
Understand the score. Research layers are inputs to a model, and the available data has limits.
Read the methodology →